Physician profile
Daniel Craviotto
NPI 1083794291
$1,544.62
in general payments reported to CMS, 2019-2025
10 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $120 · 2021: $358 · 2022: $49.32 · 2023: $315 · 2024: $320 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $583.08 | 2019-2024 | Va-Lcp, Na, Vivigen Mis Delivery System |
| Naviswiss, INC. | $241.91 | 2023 | Naviswiss Hip/Knee Navigation |
| Stryker Corporation | $240.63 | 2023-2025 | Pangea, Variax, Augment Injectable |
| Smith+Nephew, INC. | $138.68 | 2024 | Trigen Intertan |
| Zimmer Biomet Holdings, INC. | $112.01 | 2019 | |
| Illuminoss Medical, INC. | $93.05 | 2024 | |
| Cornerstone Medical Associates, INC. | $53.19 | 2024 | |
| Arthrex, INC. | $46.33 | 2019 | |
| Si-Bone, INC. | $22.55 | 2021 | |
| Encore Medical, LP | $13.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Craviotto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.